Literature DB >> 8314519

The percutaneous rotary lithotrite: a new approach to the treatment of symptomatic cholecystolithiasis.

A Gillams1, J J Donald, R C Russell, A R Hatfield, W R Lees.   

Abstract

This report evaluates the use of a new device for destruction of gall stones, the Kensey-Nash Lithotrite (Baxter Corporation, California, USA). The principle of the instrument is that of a liquidiser with an impeller that emulsifies stones. Twenty five patients were treated; 13 patients were considered unfit for conventional treatment (complex group) and 12 elected to have the procedure (non-complex group). In the complex group nine patients were treated under local anaesthesia. Only six of the 13 patients had a clear gall bladder at the end of the first procedure, but after further treatments that included cholecystoscopy, endoscopic sphincterotomy, and percutaneous cholecystolithotomy 11 patients had a gall bladder free of stones. The morbidity was high, mainly due to pain and bile leaks, causing prolonged stays in hospital (median 18 days). In the non-complex group six patients had the procedure performed under local anaesthesia. Ten patients had a successful clearance of the gall bladder, and the remaining two patients had the stones removed at cholecystoscopy. Despite good clearance, the morbidity was high, with eight emergency admissions on account of complications and a prolonged duration of stay (median 13 days). In conclusion the technique is effective, but the morbidity is high. Further development is required if this technique is to be included in the alternative treatments for the management of gall stones.

Entities:  

Mesh:

Year:  1993        PMID: 8314519      PMCID: PMC1374272          DOI: 10.1136/gut.34.6.837

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Diagnostic laparoscopic cholecystectomy.

Authors:  H M Spiro
Journal:  Lancet       Date:  1992-01-18       Impact factor: 79.321

2.  Conventional versus laparoscopic cholecystectomy and the randomized controlled trial. Cholecystectomy Study Group.

Authors:  E Neugebauer; H Troidl; W Spangenberger; A Dietrich; R Lefering
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

3.  Experimental percutaneous gallstone lithotripsy: results in swine.

Authors:  F J Miller; K R Kensey; J E Nash
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

4.  Percutaneous cholecystolithotomy.

Authors:  M J Kellett; R C Russell; J E Wickham
Journal:  Endoscopy       Date:  1989-12       Impact factor: 10.093

Review 5.  New trends in gallstone management.

Authors:  S Cheslyn-Curtis; R C Russell
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

6.  Percutaneous ablation of gallstones.

Authors:  D T Dempsey; C Contreras; R Milner; C Abrahams; J V White
Journal:  J Surg Res       Date:  1990-08       Impact factor: 2.192

7.  Percutaneous extraction of gallstones in 20 patients.

Authors:  C Cope; D R Burke; S G Meranze
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

8.  Percutaneous cholecystolithotomy: the first 60 patients.

Authors:  S G Chiverton; J A Inglis; C Hudd; M J Kellett; R C Russell; J E Wickham
Journal:  BMJ       Date:  1990-05-19

9.  Selection, management, and early outcome of 113 patients with symptomatic gall stones treated by percutaneous cholecystolithotomy.

Authors:  S Cheslyn-Curtis; A R Gillams; R C Russell; J J Donald; S P Lake; C A Ainley; A R Hatfield; W R Lees
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

10.  Indomethacin and postprandial gallbladder emptying.

Authors:  L J O'Donnell; P Wilson; P Guest; S M Catnach; A McLean; J E Wickham; P D Fairclough
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

View more
  1 in total

Review 1.  Percutaneous Biliary Endoscopy.

Authors:  Adam Khayat; Mamdouh Khayat; Michael Cline; Ahsun Riaz
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.